发明名称 Prevention and treatment of amyloidogenic disease
摘要 Provided is an amyloid A-beta fragment linked to a carrier peptide for use in inducing an immune response against A-beta and thereby preventing or treating a disease associated with amyloid deposits of A-beta in the brain of a patient, wherein the A-beta fragment consists of: 5 i) A-beta1-7 having the amino acid sequence DAEFRHD ii) A-beta3-7 having the amino acid sequence EFRHD, or iii) a multimer of i) or ii). Further provided are pharmaceutical compositions comprising the peptide and use of the peptide fragments in the manufacture of a medicament to induce an immune response against A-beta and thereby prevent or treat an associated disease.
申请公布号 NZ570086(A) 申请公布日期 2009.12.24
申请号 NZ20000570086 申请日期 2000.05.26
申请人 ELAN PHARMA INTERNATIONAL LIMITED 发明人 SCHENK, DALE B;BARD, FREDERIQUE;VASQUEZ, NICKI;YEDNOCK, TED
分类号 A61K39/395;A61K38/00;G01N33/50 主分类号 A61K39/395
代理机构 代理人
主权项
地址